Here's why these two healthcare stocks scan as no-brainer buys right now.

Vertex Pharmaceuticals continues to generate most of its revenue from its cystic fibrosis (CF) franchise. The company's ...

Olema Pharmaceuticals (OLMA) surges after Roche's breast cancer data, but caution is urged as key clinical results are ...

But then came news of Merck 's ( MRK 1.32%) plans to acquire Cidara for $221.50 per share, or a 109% premium to its prior ...

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) is one of the Hottest Small Cap Stocks to Buy Now. On November 11, Andy Hsieh from ...

UroGen Pharma Ltd. (NASDAQ:URGN) is one of the best small-cap biotech stocks to buy according to analysts.

The domestic equity markets opened lower, with Nifty 50 down 0.32% and BSE Sensex down 0.33%. Analysts suggest that despite ...

Australia on Friday blocked a A$672 million ($433 million) buyout offer for Mayne Pharma from U.S. drugmaker Cosette Pharmaceuticals, citing national interest.

QOL agreed to buy Evoke for $11 a share in a deal expected to close by the end of the year. QOL said it will fund the transaction with cash on hand. Shares of Evoke have more than doubled to $10.70 ...

Experts predict short-term volatility due to global factors, though domestic fundamentals suggest potential medium-term gains ...

Tarsus Pharmaceuticals, Inc. upgraded to Strong Buy; Xdemvy's rapid US growth and unique market lead highlight big upside.

Ajit Mishra of Religare Broking recommends three stocks, including Grasim and Aurobindo Pharma. With favourable technical setups and positive momentum, these stocks may offer opportunities for ...